Skip to main content

MARSHALL WACE, LLP

Position in DYN — Dyne Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,507,455
-$11,734,253 QoQ
Shares Held
83,147
-87.7% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,749,797,393 across 275 Biotechnology names. DYN ranks #168 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,507,455 83,147
2025-12-31 $13,241,708 676,979
2025-09-30 $38,119,219 3,013,377
2025-06-30 $4,263,122 447,807
2024-12-31 $577,243 24,501
2024-06-30 $9,654,179 273,567
2024-03-31 $1,524,684 53,705
2023-09-30 $197,585 22,052
2023-06-30 $248,085 22,052
2023-03-31 $1,524,602 132,344
2022-12-31 $255,582 22,052
2022-09-30 $824,357 64,910
2022-06-30 $2,399,546 349,279
2022-03-31 $3,367,049 349,279
2021-12-31 $4,152,927 349,279
2021-09-30 $358,124 22,052